Form 8-K - Current report:
SEC Accession No. 0001193125-25-029591
Filing Date
2025-02-19
Accepted
2025-02-19 16:05:28
Documents
17
Period of Report
2025-02-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d932072d8k.htm   iXBRL 8-K 28835
2 EX-1.1 d932072dex11.htm EX-1.1 206200
3 EX-5.1 d932072dex51.htm EX-5.1 16761
7 GRAPHIC g932072dsp44.jpg GRAPHIC 12916
8 GRAPHIC g932072g0219115452063.jpg GRAPHIC 1654
  Complete submission text file 0001193125-25-029591.txt   449363

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rcus-20250218.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20250218_lab.xml EX-101.LAB 17235
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20250218_pre.xml EX-101.PRE 10806
19 EXTRACTED XBRL INSTANCE DOCUMENT d932072d8k_htm.xml XML 3499
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

EIN.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 25639903
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)